Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?

作者: Zaki Pa , Keith De , Brine Ga , Evans Cj , Carroll Fi

DOI:

关键词: Partial agonistEtorphineOpioid antagonistEndocrinologyGTPgammaSOpioid(+)-NaloxoneOpioid receptorReceptorPharmacologyInternal medicineChemistry

摘要: In this study, we explored the relationship between regulation of surface mu-opioid receptor number, ligand-induced G protein activation (measured by [(35)]S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding) and second messenger signaling inhibition cAMP accumulation). Etorphine two isomers cis-beta-hydroxy-3-methylfentanyl (RTI-1a RTI-1b), which were full agonists for signaling, caused approximately a 50% loss receptors after 1 h treatment. Fentanyl morphine inhibiting accumulation partial stimulating [(35)S]GTPgammaS binding internalization. Although both 80% as efficacious etorphine in binding, fentanyl induced 35% receptors, whereas only 10% loss. Additionally, long- short-term treatment with opioid antagonist naloxone increases receptors. Unexpectedly, weak buprenorphine one isomer (RTI-1d) also found to cause an increase Treatment pertussis toxin (PTX) diminished agonist-induced Furthermore, abilities internalization more impaired PTX than that etorphine. significantly enhanced number 18-h buprenorphine. The results study suggest disruption coupling affects ligand-regulated mu-receptor trafficking can vary greatly ability regulate

参考文章(57)
Charles E. Inturrisi, Antonia M. Davis, d -Methadone Blocks Morphine Tolerance and N -Methyl-d-Aspartate-Induced Hyperalgesia Journal of Pharmacology and Experimental Therapeutics. ,vol. 289, pp. 1048- 1053 ,(1999)
Ellen M. Unterwald, Joshua M. Rubenfeld, Yasuo Imai, Jia-Bei Wang, George R. Uhl, Mary Jeanne Kreek, Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Molecular Brain Research. ,vol. 33, pp. 351- 355 ,(1995) , 10.1016/0169-328X(95)00143-G
B. F. Roettger, D. Pinon, L. J. Miller, J. Yingling, C. Toledo, D. Ghanekar, R. Rao, Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Molecular Pharmacology. ,vol. 51, pp. 357- 362 ,(1997)
Kazuhiko Fukuda, Shigehisa Kato, Hitoshi Morikawa, Takehiro Shoda, Kenjiro Mori, Functional Coupling of the δ-, μ-, and κ-Opioid Receptors to Mitogen-Activated Protein Kinase and Arachidonate Release in Chinese Hamster Ovary Cells Journal of Neurochemistry. ,vol. 67, pp. 1309- 1316 ,(2002) , 10.1046/J.1471-4159.1996.67031309.X
Sumita Chakrabarti, Wanling Yang, Ping-Yee Law, Horace H. Loh, The μ-opioid receptor down-regulates differently from the δ-opioid receptor: Requirement of a high affinity receptor/G protein complex formation Molecular Pharmacology. ,vol. 52, pp. 105- 113 ,(1997) , 10.1124/MOL.52.1.105
James R. Arden, Veronica Segredo, Zaijie Wang, Jelveh Lameh, Wolfgang Sadée, Phosphorylation and Agonist-Specific Intracellular Trafficking of an Epitope-Tagged μ-Opioid Receptor Expressed in HEK 293 Cells Journal of Neurochemistry. ,vol. 65, pp. 1636- 1645 ,(2002) , 10.1046/J.1471-4159.1995.65041636.X
Bryan L. Roth, David L. Willins, What's all the RAVE about receptor internalization? Neuron. ,vol. 23, pp. 629- 631 ,(1999) , 10.1016/S0896-6273(02)23443-1
Nigel T. Maidment, M. Foster Olive, Opioid regulation of pallidal enkephalin release: Bimodal effects of locally administered mu and delta opioid agonists in freely moving rats Journal of Pharmacology and Experimental Therapeutics. ,vol. 285, pp. 1310- 1316 ,(1998)
J. Zhang, S. S. G. Ferguson, L. S. Barak, S. R. Bodduluri, S. A. Laporte, P.-Y. Law, M. G. Caron, Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 7157- 7162 ,(1998) , 10.1073/PNAS.95.12.7157